Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Temozolomide × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 34 Neuroblastoma 13 Glioma 12 Brain Neoplasms 10 Rhabdomyosarcoma 7 Neoplasms 7 Astrocytoma 7 Sarcoma, Ewing 6 Recurrence 6 Oligodendroglioma 5 Medulloblastoma 5 Osteosarcoma 4 Small Cell Lung Carcinoma 3 Melanoma 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Sarcoma 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Hepatoblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Spinal Cord Neoplasms 1 Solid Tumor 1 Rhabdoid Tumor 1 Rectal Neoplasms 1

Interventions

Capecitabine 24 Oxaliplatin 22 Radiotherapy 15 Fluorouracil 13 Surgical Procedures, Operative 11 Drug Therapy 8 Chemoradiotherapy 8 Bevacizumab 8 Leucovorin 7 Consolidation Chemotherapy 7 Radiation 6 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 sintilimab 4 Neoadjuvant Therapy 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3 Cyclophosphamide 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05136326 2023-03-01

CATARTIC

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡